Resveratrol Mitigates Age-Associated Cognitive Decline Via Inhibition Of Cgas-STING-Mediated Microglial Senescence
As we age, our brains can experience a decline in cognitive function, often linked to chronic inflammation. A key player in this process is a type of brain immune cell called microglia. When these cells become “senescent” or aged, they can contribute to ongoing inflammation in the brain. Recent research has shed light on a crucial molecular pathway, known as the cGAS-STING pathway, which acts as a central alarm system within cells. This pathway detects misplaced DNA, a signal of cellular stress or damage, and in turn, triggers an inflammatory response and promotes cellular aging in microglia. This chronic inflammation can then contribute to memory problems and other cognitive issues.
A promising natural compound, resveratrol, found in grapes and other plants, has been investigated for its potential to combat these age-related changes. In studies using models of accelerated aging, resveratrol administration led to significant improvements in memory and a reduction in the markers of senescent microglia. It also suppressed the release of pro-inflammatory molecules that contribute to brain inflammation. The underlying mechanism appears to be resveratrol’s ability to inhibit the cGAS-STING pathway, essentially dampening the cellular alarm system and preventing the cascade of inflammatory events. These findings suggest that targeting this specific pathway with compounds like resveratrol could offer a new therapeutic strategy for addressing age-related cognitive decline and brain inflammation.
Source: link to paper